🇺🇸 FDA
Pipeline program

Luspatercept

2025-KLS-046-02

Unknown small_molecule active

Quick answer

Luspatercept for Transfusion-dependent Non-severe Aplastic Anemia is a Unknown program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
Transfusion-dependent Non-severe Aplastic Anemia
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials